Skip to content

A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult population

A pilot randomized control trial to reduce stress and improve psychological resilience due to COVID-19 outbreak in healthy adult population through Rajyoga meditation delivered via digital media

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027035
Enrollment
200
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Rajyoga meditation: Rajyoga mediation with the help of audio-visual aids provided by Dr Banarsi Lal Secretary medical wing of Rajyoga Meditation Education and Research Foundation, a sis

Sponsors

Dr Divya Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy population 1.Participants who complete the online assessment forms and give consent to participate 2. Age group more than 18 years of age 3. Exposed to news about the Covid crisis and access to media/ conversations amounting to at least 1 hour in 1 week 4. Self-reported anxiety/distress due to COVID 5. Ability to understand written and spoken English to give self-report 6. General physical fitment 7. Access to internet and competence to use the same 8. Willing to follow study protocol and timeline

Exclusion criteria

Exclusion criteria: 1.Subjects with history of or current neurological or psychiatric impairment, or cognitive dysfunction that could compromise data collection. 2. Subjects with severe co-morbidity (e.g. uncontrolled hypertension and uncontrolled diabetes mellitus, myocardial infarction or heart failure within 30 days of recruitment) as per investigatorâ??s assessment. 3. Those already practicing meditation or any other relaxation practice 4. Negligible or mild anxiety due to COVID-19 determined on basis of anxiety score 5. Those who have been diagnosed with COVID and their family members

Design outcomes

Primary

MeasureTime frame
1.Relief of stress assessed by perceived stress scale 2. Decrease in anxiety as measured by Anxiety ScaleTimepoint: 1 month, the parameters studied will be assessed at 15 days and 1 month post intervention

Secondary

MeasureTime frame
1. Improved psychological well-being assessed by WHO-5 well-being scale 2.Improvement in felt impact of COVID as evaluated by investigators development questionnaires.Timepoint: 1 month, the parameters studied will be assessed at 15 days and 1 month post intervention

Countries

India

Contacts

Public ContactDr Divya Jain

Superspeciality pediatric hospital and postgraduate teaching institute,Noida

divyajain27@hotmail.com9810656627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026